An evidence-based medicine model for rare and often neglected neoplastic conditions

Charles G. Fisher, Tony Goldschlager, Stefano Boriani, Peter P aul Varga, Laurence D. Rhines, Michael G. Fehlings, Alessandro Luzzati, Mark B. Dekutoski, Jeremy J. Reynolds, Dean Chou, Sigurd H. Berven, Richard P. Williams, Nasir A. Quraishi, Chetan Bettegowda, Ziya L. Gokaslan

Research output: Contribution to journalArticle

Abstract

OBJECT: The National Institutes of Health recommends strategies to obtain evidence for the treatment of rare conditions such as primary tumors of the spine (PTSs). These tumors have a low incidence and are pathologically heterogeneous, and treatment approaches are diverse. Appropriate evidence-based care is imperative. Failure to follow validated oncological principles may lead to unnecessary mortality and profound morbidity. This paper outlines a scientific model that provides significant evidence guiding the treatment of PTSs.

METHODS: A four-stage approach was used: 1) planning: data from large-volume centers were reviewed to provide insight; 2) recruitment: centers were enrolled and provided the necessary infrastructure; 3) retrospective stage: existing medical records were reviewed and completed with survival data; and 4) prospective stage: prospective data collection has been implemented. The AOSpine Knowledge Forum Tumor designed six modules: demographic, clinical, diagnostic, therapeutic, local recurrence, survival, and perioperative morbidity data fields and provided funding.

RESULTS: It took 18 months to implement Stages 1-3, while Stage 4 is ongoing. A total of 1495 tumor cases were captured and diagnosed as one of 18 PTS histotypes. In addition, a PTS biobank network has been created to link clinical data with tumor pathology and molecular analysis.

CONCLUSIONS: This scientific model has not only aggregated a large amount of PTS data, but has also established an international collaborative network of spine oncology centers. Access to large volumes of data will generate further research to guide and enhance PTS clinical management. This model could be applied to other rare neoplastic conditions. Clinical trial registration no.: NCT01643174 (ClinicalTrials.gov).

Original languageEnglish
Pages (from-to)704-710
Number of pages7
JournalJournal of Neurosurgery: Spine
Volume21
Issue number5
DOIs
Publication statusPublished - Nov 1 2014

    Fingerprint

Keywords

  • AOSKFT = AOSpine International Knowledge Forum Tumor
  • FFPE = formalin-fixed paraffinembedded
  • network
  • NIH = National Institutes of Health
  • oncology
  • primary tumor
  • PTS = primary tumor of the spine
  • rare disease
  • scientific model
  • spine
  • surgery
  • WBB = Weinstein-Boriani-Biagini

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Fisher, C. G., Goldschlager, T., Boriani, S., Varga, P. P. A., Rhines, L. D., Fehlings, M. G., Luzzati, A., Dekutoski, M. B., Reynolds, J. J., Chou, D., Berven, S. H., Williams, R. P., Quraishi, N. A., Bettegowda, C., & Gokaslan, Z. L. (2014). An evidence-based medicine model for rare and often neglected neoplastic conditions. Journal of Neurosurgery: Spine, 21(5), 704-710. https://doi.org/10.3171/2014.7.SPINE13954